Try our mobile app

Published: 2020-10-29 16:51:21 ET
<<<  go to NATI company page
EX-99.1 2 ex99-1q3earnings.htm EXHIBIT 99.1 Q3 EARNINGS RELEASE Contact:    Marissa Vidaurri
 Head of Investor Relations
 (512) 683-5215


NI Reports Third Quarter Results
Revenue of $308 million, above midpoint of guidance


Q3 2020 Summary
GAAP Revenue of $308 million, down 9 percent year over year
Fully diluted GAAP EPS of $(0.04) and fully diluted non-GAAP EPS of $0.23
EBITDA of $19 million for the third quarter
Cash and short-term investments of $290 million as of September 30, 2020

First Three Quarters of 2020 Summary
GAAP Revenue of $919 million, down 7 percent year over year
Fully diluted GAAP EPS of $1.06 and fully diluted non-GAAP EPS of $0.74
EBITDA of $242 million for the first nine months of 2020

AUSTIN, Texas - Oct. 29, 2020 - National Instruments (Nasdaq: NATI) today announced Q3 2020 revenue of $308 million, down 9 percent year over year, and up 2 percent sequentially.

In Q3 2020 the value of the company's orders was down 7 percent year over year; orders over $20,000 were down 4 percent year over year; and orders under $20,000 were down 11 percent year over year. For Q3, year over year orders in the Americas region were relatively flat, in EMEA orders were down 16 percent, and in APAC orders were down 7 percent during the quarter.

Before the second quarter of 2020 we included order value and net sales attributable to our operations in India within the EMEA region. In the second quarter of 2020, we began including these amounts within the APAC geographic region, to reflect recent changes within our organizational structure.

Geographic revenue in U.S. dollar terms for Q3 2020 compared with Q3 2019 was down 11 percent in the Americas, down 5 percent in APAC and down 12 percent in EMEA. Excluding the impact of foreign currency exchange, revenue was down 11 percent in the Americas, down 3 percent in APAC and down 13 percent in EMEA. Historical revenue from these three regions can be found on NI’s investor website at www.ni.com/nati

In Q3, GAAP gross margin was 70 percent and non-GAAP gross margin was 74 percent. Total GAAP operating expenses were $218 million, up 1 percent year over year. Total non-GAAP operating expenses were down 3 percent year over year at $189 million. GAAP operating loss was $(2) million with non-GAAP operating income of $40 million. GAAP net loss for Q3 was $(5) million and non-GAAP net income was $30 million, with GAAP fully diluted EPS  of ($0.04) and non-GAAP fully diluted EPS of $0.23, above the midpoint of our guidance. EBITDA, or Earnings Before Interest, Taxes, Depreciation and Amortization, was $19 million for Q3.

For the first nine months of 2020, GAAP revenue was $919 million, down 7 percent year over year, the value of the company's total orders was down 6 percent year over year, with GAAP net income of $139 million, up 34% year over year, and GAAP fully diluted EPS of $1.06.

“We have and will continue to take a broad range of actions to ignite growth. Building on our unique software position, we believe we have the opportunity to once again modernize and disrupt our industry.” said Eric Starkloff, NI CEO. “We remain focused on execution in the areas of our business that can drive our growth even within the constraints of an overall weaker spending environment. The actions we are taking, on both reductions and investments, are focused on achieving long-term growth.”

“We delivered third quarter revenue above the midpoint of guidance despite the current economic environment. While we have seen positive signs in our business, we remain cautious to the uncertainty that lies ahead,” said Karen Rapp, NI CFO. “We remain committed to the execution of our growth and profitability strategy in pursuit of our long-term financial targets. We believe our strong balance sheet and cash position provide us the capability to keep our capital allocation priorities unchanged as we stay committed to shareholder value."

As of September 30, 2020, NI had $290 million in cash and short-term investments. During the third quarter, NI paid $34 million in dividends and repurchased 446,502 shares of our common stock at an average price of $34.86 per share. The NI Board of Directors approved a quarterly dividend of $0.26 per share payable on December 7, 2020, to stockholders of record on November 16, 2020.
The company’s non-GAAP results exclude, as applicable, the impact of purchase accounting fair value adjustments, stock-based compensation, amortization of acquisition-related intangibles, acquisition-related transaction and integration costs, taxes levied on the transfer of acquired intellectual property, foreign exchange loss on acquisitions, restructuring charges, tax reform charges, disposal gains on buildings and related charitable contributions, tax effects related to businesses held for sale, gain on sale of businesses, and capitalization and amortization of internally developed software costs. Reconciliations of the company’s GAAP and non-GAAP results are included as part of this news release.

Guidance

NI currently expects Q4 GAAP revenue to be in the range of $333 million to $363 million and Q4 non-GAAP revenue, which adjusts for the impact of purchase price accounting related to OptimalPlus, to be in the range of $335 million to $365 million. The company currently expects that GAAP fully diluted EPS will be in the range of $(0.04) to $0.10 for Q4, with non-GAAP fully diluted EPS expected to be in the range of $0.32 to $0.46. Included in our EPS guidance is a restructuring charge of $0.13 which relates to a reduction in our global workforce of approximately 9%.

Conference Call Information

Interested parties can listen to the Q3 2020 earnings conference call with NI management today, October 29, at 4:00 p.m. CT at ni.com/call or by dialing 855-212-2361 and entering confirmation code 7456239  ten minutes prior to the call start time. Replay information is available by calling (855) 859-2056 and entering confirmation code 7456239 , shortly after the call through November 1 at 10:00 p.m. CT or by visiting the company’s website at ni.com/call.

Non-GAAP Presentation

In addition to disclosing results determined in accordance with GAAP, NI discloses certain non-GAAP operating results and non-GAAP information that exclude certain charges. In this news release, the company has presented its revenue, gross profit, gross margin, operating expenses, operating income, operating margin, provision for income taxes, net income and fully diluted EPS for the three and nine months ended September 30, 2020 and 2019, on a GAAP and non-GAAP basis. NI is also providing guidance on its non-GAAP revenue and non-GAAP fully diluted EPS.

When presenting non-GAAP information, the company includes a reconciliation of the non-GAAP results to the GAAP results. Management believes that including the non-GAAP results assists investors in assessing the company’s operational performance and its performance relative to its competitors. The company presents these non-GAAP results as a complement to results provided in accordance with GAAP, and these results should not be regarded as a substitute for GAAP. Management uses these non-GAAP measures to manage and assess the profitability and performance of its business and does not consider purchase accounting fair value adjustments, stock-based compensation expense, amortization of acquisition-related intangibles, acquisition-related transaction and integration costs, taxes levied on the transfer of acquired intellectual property, foreign exchange loss on acquisitions, restructuring charges, tax reform charges, disposal gains on buildings and related charitable contributions, tax effects related to businesses held for sale, gain on sale of businesses, and capitalization and amortization of internally developed software costs in managing its operations. Specifically, management uses non-GAAP measures to plan and forecast future periods; to establish operational goals; to compare with its business plan and individual operating budgets; to measure management performance for the purposes of executive compensation, including payments to be made under bonus plans; to assist the public in measuring the company’s performance relative to the company’s long-term public performance goals; to allocate resources; and, relative to the company’s historical financial performance, to enable comparability between periods. Management also considers such non-GAAP results to be an important supplemental measure of its performance.

This news release discloses the company’s EBITDA for the three and nine months ended September 30, 2020 and 2019. The company believes that including the EBITDA results assists investors in assessing the company’s operational performance relative to its competitors. A reconciliation of EBITDA to GAAP net income is included with this news release.

Forward-Looking Statements

This release contains “forward-looking statements” including statements regarding we have and will continue to take a broad range of actions to ignite growth; building on our unique software position, we believe we have the opportunity to once again modernize and disrupt our industry; we remain focused on execution in the areas of our business that can drive our growth even within the constraints of an overall weaker spending environment; the actions we are taking, on both reductions and investments, are focused on achieving  long-term growth; while we have seen positive signs in our business,we remain cautious to the uncertainty that lies ahead; we remain committed to the execution of our growth and profitability strategy in pursuit of our long-term financial targets; we believe our strong balance sheet and cash position provide us the capability to keep our capital allocation priorities unchanged as we stay committed to shareholder value; expecting Q4 GAAP revenue to be in the range of $333 million to $363 million, expecting Q4 non-GAAP revenue, which adjusts for the impact of purchase accounting fair value adjustments related to OptimalPlus, to be in the range of $335 million to $365 million, and expecting that GAAP fully diluted EPS will be in the range of $(0.04) to $0.10 for Q4, with non-GAAP fully diluted EPS expected to be in the range of $0.32 to $0.46; and included in our EPS guidance is a restructuring charge of $0.13 which relates to a reduction in our global workforce of approximately 9%. These statements are subject to a number of risks and uncertainties, including risks and uncertainties related to the COVID-19 virus and further economic and market disruptions resulting from COVID-19; further adverse changes or fluctuations in the global economy; further adverse fluctuations in our industry; foreign exchange fluctuations; changes in the current global trade regulatory environment; fluctuations in customer demands and markets; fluctuations in demand for NI products including orders from NI’s large customers; component shortages; delays in the release of new products; NI’s ability to effectively manage its operating expenses; manufacturing inefficiencies and the level of capacity utilization; the impact of any recent or future acquisitions or divestitures by NI (including the ability to successfully operate or integrate the acquired company’s business into NI, the ability to retain and integrate the acquired company’s employees into NI, and the ability to realize the expected benefits of the acquisition); NI’s ability to achieve the benefits of employee restructuring plans and possible changes in the size and timing of the related charges; expense overruns; and adverse effects of price changes or effective tax rates. Actual results may differ materially from the expected results. The company directs readers to its Form 10-K for the year ended Dec. 31, 2019, its Form 10-Q for the quarter ended June 30, 2020 and the other documents it files with the SEC for other risks associated with the company’s future performance. These documents contain and identify important factors that could cause our actual results to differ materially from those contained in our forward-looking statements.

All information in this release is as of the date above. The company undertakes no duty to update any forward-looking statement to conform the statement to actual results or changes in the company’s expectations.

About NI
At NI, we bring together the people, ideas and technology so forward thinkers and creative problem solvers can take on humanity’s biggest challenges. From data and automation to research and validation, we provide the tailored, software-connected systems engineers and enterprises need to Engineer Ambitiously™ every day. (NATI-F)]

LabVIEW, National Instruments, NI and ni.com are trademarks of National Instruments. Other product and company names listed are trademarks or trade names of their respective companies.


National Instruments
Condensed Consolidated Balance Sheets
(in thousands)
 
September 30,
December 31,
 
2020
2019
 
(unaudited) 
 
Assets
 
 
Current assets:
 
 
Cash and cash equivalents
$
197,319 
 
$
194,616 
 
Short-term investments
92,853 
 
237,983 
 
Accounts receivable, net
214,620 
 
248,872 
 
Inventories, net
209,558 
 
200,410 
 
Prepaid expenses and other current assets
72,956 
 
65,477 
 
Total current assets
787,306 
 
947,358 
 
     
Property and equipment, net
253,073 
 
243,717 
 
Goodwill
487,101 
 
262,242 
 
Intangible assets, net
183,067 
 
84,083 
 
Operating lease right-of-use assets
69,395 
 
70,407 
 
Other long-term assets
63,930 
 
44,082 
 
Total assets
$
1,843,872 
 
$
1,651,889 
 
 
   
Liabilities and Stockholders' Equity
   
Current liabilities:
   
Accounts payable and accrued expenses
$
48,886 
 
$
52,192 
 
Accrued compensation
53,496 
 
47,732 
 
Deferred revenue - current
116,871 
 
131,445 
 
Operating lease liabilities - current
16,177 
 
13,431 
 
Other taxes payable
41,604 
 
40,607 
 
Debt, current
3,500 
 
— 
 
Other current liabilities
50,259 
 
20,716 
 
Total current liabilities
330,793 
 
306,123 
 
 
   
Deferred income taxes
41,514 
 
14,065 
 
Liability for uncertain tax positions
6,867 
 
6,652 
 
Income tax payable - non-current
61,628 
 
69,151 
 
Deferred revenue - non-current
34,210 
 
33,480 
 
Operating lease liabilities - non-current
37,767 
 
40,650 
 
Debt, noncurrent
84,289 
 
— 
 
Other long-term liabilities
7,606 
 
5,418 
 
Total liabilities
$
604,674 
 
$
475,539 
 
 
   
Stockholders' equity:
   
Common stock
1,312 
 
1,305 
 
Additional paid-in capital
1,012,656 
 
953,578 
 
Retained earnings
247,970 
 
242,537 
 
Accumulated other comprehensive loss
(22,740)
 
(21,070)
 
Total stockholders' equity
1,239,198 
 
1,176,350 
 
Total liabilities and stockholders' equity
$
1,843,872 
 
$
1,651,889 
 


National Instruments
Condensed Consolidated Statements of Income
(in thousands, except per share data, unaudited)
 
 
 
 
 
Three Months Ended
Nine Months Ended
 
September 30,
September 30,
 
2020
2019
2020
2019
 
       
Net sales:
       
Product
$
269,651 
 
$
305,247 
 
$
809,890 
 
$
882,747 
 
Software maintenance
38,473 
 
35,195 
 
108,944 
 
103,000 
 
Total net sales
308,124 
 
340,442 
 
918,834 
 
985,747 
 
 
 
 
 
 
Cost of sales:
 
 
 
 
Product
88,370 
 
84,127 
 
254,236 
 
240,056 
 
Software maintenance
3,893 
 
1,788 
 
7,689 
 
5,700 
 
Total cost of sales
92,263 
 
85,915 
 
261,925 
 
245,756 
 
 
 
 
 
 
Gross profit
215,861 
 
254,527 
 
656,909 
 
739,991 
 
 
70.1%
74.8%
71.5%
75.1%
Operating expenses:
       
Sales and marketing
109,774 
 
113,922 
 
330,939 
 
352,340 
 
Research and development
70,802 
 
66,558 
 
206,648 
 
200,981 
 
General and administrative
37,431 
 
35,711 
 
92,980 
 
92,639 
 
Total operating expenses
218,007 
 
216,191 
 
630,567 
 
645,960 
 
Gain on sale of business/assets
— 
 
26,842 
 
159,753 
 
26,842 
 
Operating income
(2,146)
 
65,178 
 
186,095 
 
120,873 
 
Other (expense) income:
(2,001)
 
2,249 
 
(2,584)
 
5,379 
 
Income before income taxes
(4,147)
 
67,427 
 
183,511 
 
126,252 
 
Provision for income taxes
475 
 
15,783 
 
44,588 
 
22,697 
 
Net (loss) income
$
(4,622)
 
$
51,644 
 
$
138,923 
 
$
103,555 
 
 
       
Basic (loss) earnings per share
$
(0.04)
 
$
0.39 
 
$
1.06 
 
$
0.79 
 
Diluted (loss) earnings per share
$
(0.04)
 
$
0.39 
 
$
1.06 
 
$
0.78 
 
 
       
Weighted average shares outstanding -
       
Basic
131,419 
 
131,385 
 
131,017 
 
131,896 
 
Diluted
131,419 
 
131,889 
 
131,671 
 
132,890 
 
 
       
Dividends declared per share
$
0.26 
 
$
0.25 
 
$
0.78 
 
$
0.75 
 


 
Condensed Consolidated Statements of Cash Flows
(in thousands, unaudited)
 
Nine Months Ended September 30,
 
2020
2019
   
Cash flow from operating activities:
   
Net income
$
138,923 
 
$
103,555 
 
Adjustments to reconcile net income to net cash provided by operating activities:
 
 
Disposal gains on sale of business/asset
(159,753)
 
(26,842)
 
Depreciation and amortization
61,228 
 
54,546 
 
Stock-based compensation
42,556 
 
38,054 
 
Deferred income taxes
(932)
 
(1,461)
 
Net change in operating assets and liabilities
26,762 
 
(18,507)
 
Net cash provided by operating activities
108,784 
 
149,345 
 
     
Cash flow from investing activities:
   
Acquisitions, net of cash received
(334,981)
 
— 
 
Capital expenditures
(36,573)
 
(47,183)
 
Proceeds from sale of business/assets, net of cash divested
160,266 
 
32,492 
 
Capitalization of internally developed software
(2,806)
 
(7,179)
 
Additions to other intangibles
(1,045)
 
(1,132)
 
Acquisitions of equity-method investments
(7,502)
 
(13,670)
 
Purchases of short-term investments
(206,330)
 
(141,074)
 
Sales and maturities of short-term investments
351,597 
 
204,046 
 
Net cash (used in) provided by investing activities
(77,374)
 
26,300 
 
     
Cash flow from financing activities:
   
Proceeds from revolving loan facility
20,000 
 
— 
 
Proceeds from term loan
70,000 
 
— 
 
Payments on term loan
(875)
 
— 
 
Debt issuance costs
(1,480)
 
— 
 
Proceeds from issuance of common stock
24,971 
 
25,823 
 
Repurchase of common stock
(39,244)
 
(137,171)
 
Dividends paid
(102,396)
 
(99,083)
 
Net cash used in financing activities
(29,024)
 
(210,431)
 
 
 
 
Impact of changes in exchange rates on cash
317 
 
(1,827)
 
     
Net change in cash and cash equivalents
2,703 
 
(36,613)
 
Cash and cash equivalents at beginning of period
194,616 
 
259,386 
 
Cash and cash equivalents at end of period
$
197,319 
 
$
222,773 
 



The following tables provide details with respect to the amount of GAAP charges related to stock-based compensation, amortization of acquisition-related intangibles and fair value adjustments, acquisition-related transaction and integration costs, capitalization and amortization of internally developed software costs, restructuring charges, gains on sale of business/assets, and other that were recorded in the line items indicated below (unaudited) (in thousands)
         
 
Three Months Ended
Nine Months Ended
 
September 30,
September 30,
         
 
2020
2019
2020
2019
Stock-based compensation
       
Cost of sales
$
1,051 
 
$
904 
 
$
2,787 
 
$
2,587 
 
Sales and marketing
5,184 
 
5,231 
 
16,826 
 
14,745 
 
Research and development
4,692 
 
4,099 
 
12,640 
 
12,029 
 
General and administrative
4,293 
 
3,158 
 
10,301 
 
8,693 
 
Provision for income taxes
(3,854)
 
(2,128)
 
(8,260)
 
(7,904)
 
Total
$
11,366 
 
$
11,264 
 
$
34,294 
 
$
30,150 
 
         
Amortization of acquisition-related intangibles and fair value adjustments
       
Net sales
$
1,299 
 
— 
 
1,299 
 
$
— 
 
Cost of sales
4,198 
 
$
833 
 
$
5,579 
 
2,525 
 
Sales and marketing
2,334 
 
492 
 
3,300 
 
1,485 
 
Research and development
28 
 
28 
 
84 
 
84 
 
Other expense (income)
121 
 
124 
 
363 
 
285 
 
Provision for income taxes
(1,658)
 
(190)
 
(1,948)
 
(576)
 
Total
$
6,322 
 
$
1,287 
 
$
8,677 
 
$
3,803 
 
         
Acquisition transaction and integration costs, restructuring charges, and other(1)(2)(3)
       
Cost of sales
$
(13)
 
$
— 
 
$
 
$
— 
 
Sales and marketing
1,158 
 
2,993 
 
8,771 
 
8,290 
 
Research and development
374 
 
244 
 
5,190 
 
899 
 
General and administrative(1)(3)
10,210 
 
7,998 
 
12,595 
 
9,525 
 
Gain on sale of business/assets(1)(2)
— 
 
(26,842)
 
(159,753)
 
(26,842)
 
Other expense (income)
270 
 
— 
 
397 
 
— 
 
Provision for income taxes
(712)
 
3,090 
 
33,965 
 
1,240 
 
Total
$
11,287 
 
$
(12,517)
 
$
(98,828)
 
$
(6,888)
 
(1): During the third quarter of 2019, the company recognized a gain of $27 million related to the sale of an office building, presented within "Gain on sale of business/assets". The company also recognized a charitable contribution expense of $7 million related to an infrequent donation using a portion of the proceeds from the sale of the building, presented within "General and administrative".
(2): During the first quarter of 2020, the company recognized a gain of $160 million related to the divestiture of AWR, presented within "Gain on sale of business/assets".
(3): During the third quarter of 2020, we recognized $5 million of compensation expense related to the replacement of unvested options acquired from OptimalPlus. These amounts were accounted for as post-combination expense and will be recognized over the required service period.
         
Capitalization and amortization of internally developed software costs
       
Cost of sales
$
6,769 
 
$
6,954 
 
$
20,995 
 
$
20,073 
 
Research and development
302 
 
(2,682)
 
(2,794)
 
(7,179)
 
Provision for income taxes
(1,485)
 
(897)
 
(3,822)
 
(2,708)
 
Total
$
5,586 
 
$
3,375 
 
$
14,379 
 
$
10,186 
 


National Instruments
Reconciliation of GAAP to Non-GAAP Measures
(in thousands, unaudited)
 
 
 
 
 
 
Three Months Ended
Nine Months Ended
 
September 30,
September 30,
 
2020
2019
2020
2019
         
Reconciliation of Net sales to Non-GAAP Net sales
       
Net sales, as reported
$
308,124 
 
340,442 
 
918,834 
 
$
985,747 
 
plus: Impact of purchase accounting fair value adjustments
1,299 
 
— 
 
1,299 
 
— 
 
Non-GAAP net sales
$
309,423 
 
340,442 
 
920,133 
 
$
985,747 
 
         
Reconciliation of Gross Profit to Non-GAAP Gross Profit
   
Gross profit, as reported
$
215,861 
 
$
254,527 
 
$
656,909 
 
$
739,991 
 
Stock-based compensation
1,051      
904     
2,787     
2,587      
Amortization of acquisition-related intangibles and fair value adjustments
5,497      
833    
6,878     
2,525     
Acquisition transaction and integration costs, restructuring charges and other
(13)
 
— 
 
 
— 
 
Amortization of internally developed software costs
6,769     
6,954     
20,995     
20,073     
Non-GAAP gross profit
$
229,165 
 
$
263,218 
 
$
687,576 
 
$
765,176 
 
Non-GAAP gross margin
74.1%
77.3%
74.7%
77.6%
         
Reconciliation of Operating Expenses to Non-GAAP Operating Expenses
   
Operating expenses, as reported
$
218,007 
 
$
216,191 
 
$
630,567 
 
$
645,960 
 
Stock-based compensation
(14,169)
 
(12,488)
 
(39,767)
 
(35,467)
 
Amortization of acquisition-related intangibles and fair value adjustments
(2,362)
 
(520)
 
(3,384)
 
(1,569)
 
Acquisition transaction and integration costs, restructuring charges and other
(11,742)
 
(11,235)
 
(26,556)
 
(18,714)
 
Capitalization of internally developed software costs
(302)
 
2,682 
 
2,794 
 
7,179 
 
Non-GAAP operating expenses
$
189,432 
 
$
194,630 
 
$
563,654 
 
$
597,389 
 
         
Reconciliation of Operating Income to Non-GAAP Operating Income
   
Operating income, as reported
$
(2,146)
 
$
65,178 
 
$
186,095 
 
$
120,873 
 
Stock-based compensation
15,220 
 
13,392 
 
42,554 
 
38,054 
 
Amortization of acquisition-related intangibles and fair value adjustments
7,859 
 
1,353 
 
10,262 
 
4,094 
 
Acquisition transaction and integration costs, restructuring charges and other
11,729 
 
11,235 
 
26,563 
 
18,714 
 
Net amortization of internally developed software costs
7,071 
 
4,272 
 
18,201 
 
12,894 
 
Gain on sale of business/assets
— 
 
(26,842)
 
(159,753)
 
(26,842)
 
Non-GAAP operating income
$
39,733 
 
$
68,588 
 
$
123,922 
 
$
167,787 
 
Non-GAAP operating margin
12.8%
20.1%
13.5%
17.0%
         
Reconciliation of Provision for income taxes to Non-GAAP Provision for income taxes(1)
   
Provision for income taxes, as reported
$
475 
 
$
15,783 
 
$
44,588 
 
$
22,697 
 
Stock-based compensation
3,854 
 
2,128 
 
8,260 
 
7,904 
 
Amortization of acquisition-related intangibles and fair value adjustments
1,658 
 
190 
 
1,948 
 
576 
 
Acquisition transaction and integration costs, restructuring charges and other
712 
 
2,587 
 
2,794 
 
4,437 
 
Net amortization of internally developed software costs
1,485 
 
897 
 
3,822 
 
2,708 
 
Gain on sale of business/assets
— 
 
(5,677)
 
(36,759)
 
(5,677)
 
Tax reform charge
— 
 
(2,774)
 
— 
 
(2,774)
 
Non-GAAP provision for income taxes(1)
$
8,184 
 
$
13,134 
 
$
24,653 
 
$
29,871 
 
(1): The income tax effect related to each non-GAAP item is calculated based on the tax laws and statutory income tax rates applicable in the tax jurisdiction(s) of the underlying non-GAAP adjustment, and considers the current and deferred tax impact of those adjustments.



Reconciliation of GAAP Net (Loss) Income and Diluted EPS to Non-GAAP Net Income, Non-GAAP Diluted EPS, and EBITDA
(in thousands, except per share data, unaudited)
 
 
 
 
 
 
Three Months Ended
Nine Months Ended
 
September 30,
September 30,
 
2020
2019
2020
2019
 
 
 
 
 
Net (loss) income, as reported
$
(4,622)
 
$
51,644 
 
$
138,923 
 
$
103,555 
 
Adjustments to reconcile net (loss) income to non-GAAP net income:
       
  Stock-based compensation
15,220 
 
13,392 
 
42,554 
 
38,054 
 
Amortization of acquisition-related intangibles and fair value adjustments
7,980 
 
1,477 
 
10,625 
 
4,379 
 
Acquisition transaction and integration costs, restructuring charges and other
11,999 
 
11,235 
 
26,960 
 
18,714 
 
Net amortization of internally developed software costs
7,071 
 
4,272 
 
18,201 
 
12,894 
 
Gain on sale of business/assets
— 
 
(26,842)
 
(159,753)
 
(26,842)
 
Income tax effects and adjustments(1)
(7,709)
 
2,649 
 
19,935 
 
(7,174)
 
Non-GAAP net income
$
29,939 
 
$
57,827 
 
$
97,445 
 
$
143,580 
 
Non-GAAP net margin
9.7%
17.0%
10.6%
14.6%
 
Diluted EPS, as reported
$
(0.04)
 
$
0.39 
 
$
1.06 
 
$
0.78 
 
Adjustment to reconcile diluted EPS to non-GAAP diluted EPS
       
 Stock-based compensation
0.12 
 
0.10 
 
0.32 
 
0.28 
 
Amortization of acquisition-related intangibles and fair value adjustments
0.06 
 
0.01 
 
0.08 
 
0.03 
 
Acquisition transaction and integration costs, restructuring charges and other
0.10 
 
0.09 
 
0.20 
 
0.14 
 
Net amortization of internally developed software costs
0.05 
 
0.03 
 
0.14 
 
0.10 
 
Gain on sale of business/assets
— 
 
(0.20)
 
(1.21)
 
(0.20)
 
Income tax effects and adjustments(1)
(0.06)
 
0.02 
 
0.15 
 
(0.05)
 
Non-GAAP diluted EPS
$
0.23 
 
$
0.44 
 
$
0.74 
 
$
1.08 
 
(1): The income tax effect related to each non-GAAP item is calculated based on the tax laws and statutory income tax rates applicable in the tax jurisdiction(s) of the underlying non-GAAP adjustment, and considers the current and deferred tax impact of those adjustments.
 
       
Weighted average shares outstanding - Diluted
131,419
131,889
131,671
132,890


 
 
Three Months Ended
 
Nine Months Ended
 
 
September 30,
 
September 30,
 
 
2020
 
2019
 
2020
 
2019
Net income, as reported
 
$
(4,622)
   
$
51,644 
   
$
138,923 
   
$
103,555 
 
Adjustments to reconcile net income to EBITDA:
 
 
 
 
 
 
 
 
     Interest expense (income), net
 
560 
   
(1,923)
   
(2,608)
   
(6,155)
 
     Tax expense
 
475 
   
15,783 
   
44,588 
   
22,697 
 
     Depreciation and amortization
 
22,887 
 
 
18,562 
 
 
61,228 
   
54,546 
 
EBITDA
 
$
19,300 
   
$
84,066 
   
$
242,131 
   
$
174,643 
 
Weighted average shares outstanding - Diluted
 
131,419 
   
131,889 
   
131,671 
   
132,890 
 
 
 
 
 
 
 
 
 
 

Reconciliation of GAAP Diluted EPS to Non-GAAP Diluted EPS Guidance
(unaudited)
 
Three Months Ended
 
December 31, 2020
 
 
 
 
Low
High
GAAP Diluted EPS, guidance
$
(0.04)
 
$
0.10 
 
Adjustment to reconcile diluted EPS to non-GAAP diluted EPS:
 
 
Stock-based compensation
0.12    
0.12     
Amortization of acquisition-related intangibles and fair value adjustments
0.06    
0.06     
Acquisition transaction and integration costs, restructuring charges, and other
0.20 
 
0.20 
 
Net amortization of software development costs
0.04 
 
0.04 
 
Income tax effects and adjustments(1)
(0.06)
 
(0.06)
 
Non-GAAP Diluted EPS, guidance
$
0.32 
 
$
0.46 
 
(1): The income tax effect related to each non-GAAP item is calculated based on the tax laws and statutory income tax rates applicable in the tax jurisdiction(s) of the underlying non-GAAP adjustment, and considers the current and deferred tax impact of those adjustments.

Reconciliation of GAAP Revenue to Non-GAAP Revenue, Guidance
(unaudited)
 
Three Months Ended
   
 
December 31,
   
 
 
2020
 
2019
 
Percent Inc/(Dec)
 
 
(midpoint)
 
   
GAAP Revenue, guidance
 
$
348,000 
 
$
367,468 
 
(5)%
plus: Impact of purchase accounting fair value adjustments
 
2,000 
 
   
Non-GAAP Revenue, guidance
 
$
350,000 
 
$
367,468 
 
(5)%